President Donald J. Trump has reclassified state-licensed medical marijuana, easing restrictions on research and allowing tax deductions for state-licensed medical marijuana companies.
| PULSE POINTS |
❓ WHAT HAPPENED: President Donald J. Trump’s Acting Attorney General, Todd Blanche, signed an order on Thursday reclassifying state-licensed medical marijuana from Schedule I to Schedule III, marking a historic shift in federal drug policy. 📰 DETAIL: The reclassification does not legalize marijuana federally but changes its regulation, allowing for tax deductions for state-licensed medical marijuana companies and easing research barriers. This move aligns with President Trump’s directive to expedite the reclassification process, which had been stalled under the former Biden government. Blanche credited the move to Trump’s “decisive leadership.” 🎯 IMPACT: The order legitimizes medical marijuana programs in 40 states, providing a tax break for operators and facilitating research. It also sets up a system for state-licensed producers to register with the Drug Enforcement Administration (DEA), potentially influencing future federal marijuana policies. In a social media post outlining the reform, Blanche said there would be “a new, expedited hearing with set deadlines, to fully reschedule marijuana” in the near future. 💬 KEY QUOTE: “This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information.” – Todd Blanche 👀 FLASHBACK: The Marijuana Tax Act of 1937 marked the beginning of federal marijuana prohibition, which has persisted despite widespread state-level decriminalization and legalization for medical and recreational use. President Trump signed an executive order removing federal legal hurdles to medical marijuana and cannabidiol (CBD) research and tasking Blanche with expediting today’s rescheduling in December. |
Under the decisive leadership of @POTUS, this Department of Justice is delivering on his promise to improve American healthcare. This includes:
• Immediately rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule IIl
• Ordering a new,… pic.twitter.com/DUtqKQgavl
— Acting AG Todd Blanche (@DAGToddBlanche) April 23, 2026
Join Pulse+ to comment below, and receive exclusive e-mail analyses.
